Editorial (Thematic Issue: Mechanisms of Atherogenesis and Development of Anti-Atherosclerotic Therapy)

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|9|1103-1106

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.9, 2015-03, pp. : 1103-1106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Novel Targets and Biomarkers for Anti-atherosclerotic Therapy)

By  

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5837-5839

Bentham Science Publishers

Access to resources Recommend Favorite

Direct Anti-Atherosclerotic Therapy; Development of Natural Anti-Atherosclerotic Drugs Preventing Cellular Cholesterol Retention

By  

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5909-5928

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Pathogenetic Mechanisms of CLL - A Target in Therapy)

By  

Current Cancer Drug Targets, Vol. 16, Iss. 8, 2016-10 ,pp. : 651-651

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Targeting Telomere Maintenance Mechanisms in Cancer Therapy)

By  

Current Pharmaceutical Design, Vol. 20, Iss. 41, 2014-12 ,pp. : 6359-6360

Bentham Science Publishers

Access to resources Recommend Favorite

Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy

By  

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5954-5962

Bentham Science Publishers

Access to resources Recommend Favorite